CSL’s world-class R&D organization continues to evolve as a biotechnology leader by advancing high-quality science and technologies developed by our own high-caliber scientists and innovative collaborations. R&D utilizes its expertise in our strategic platforms – plasma technology; recombinant technology; cell and gene therapy; and vaccines technology. This ensures CSL can develop and deliver innovative medicines and vaccines that address unmet medical needs, help prevent infectious disease and protect public health, and help patients lead full lives.
)
